180 Life Sciences (ATNF)
NASDAQ:ATNF
US Market

180 Life Sciences (ATNF) Stock Price & Analysis

181 Followers

ATNF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.18 - $71.40
Previous Close$3.24
Volume954.65K
Average Volume (3M)4.34M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-0.4
Beta1.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-7.72
Shares Outstanding24,400,000
R-Squared0.02
Standard Deviation0.95
10 Day Avg. Volume2,593,697
30 Day Avg. Volume4,344,881
Price to Book (P/B)-6.87
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha0.11
Number of Analyst Covering0


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ATNF FAQ

What was 180 Life Sciences’s price range in the past 12 months?
180 Life Sciences lowest stock price was $1.18 and its highest was $71.40 in the past 12 months.
    What is 180 Life Sciences’s market cap?
    Currently, no data Available
    When is 180 Life Sciences’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were 180 Life Sciences’s earnings last quarter?
    Currently, no data Available
    Is 180 Life Sciences overvalued?
    According to Wall Street analysts 180 Life Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does 180 Life Sciences pay dividends?
      180 Life Sciences does not currently pay dividends.
      What is 180 Life Sciences’s EPS estimate?
      180 Life Sciences’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does 180 Life Sciences have?
      180 Life Sciences has 2,238,025 shares outstanding.
        What happened to 180 Life Sciences’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of 180 Life Sciences?
        Currently, no hedge funds are holding shares in ATNF

        ---

        180 Life Sciences Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Negative
        20 days / 200 days
        Momentum
        -93.67%
        12-Months-Change

        Fundamentals

        Return on Equity
        -50.45%
        Trailing 12-Months
        Asset Growth
        -47.23%
        Trailing 12-Months
        This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
        Learn more about TipRanks Smart Score

        Company Description

        180 Life Sciences

        KBL Merger Corp. IV is a blank check company, which focuses on acquiring an operating company in the healthcare and related wellness industry. The company was founded on September 7, 2016 and is headquartered in Newark, DE.

        ---

        Forecast EPS vs Actual EPS

        Currently, no data available
        Please return soon. This page is being updated.

        Similar Stocks
        Company
        Price & Change
        Follow
        Catalyst Biosciences
        eFFECTOR Therapeutics
        Immix Biopharma, Inc.
        Cellectar Biosciences

        Popular Stocks

        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis